169 related articles for article (PubMed ID: 9541036)
1. Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestions.
Scharman EJ
J Toxicol Clin Toxicol; 1998; 36(1-2):19-25. PubMed ID: 9541036
[TBL] [Abstract][Full Text] [Related]
2. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.
Clark RF; Chen R; Williams SR; Johnson CL; Harchelroad F
J Toxicol Clin Toxicol; 1996; 34(2):163-7. PubMed ID: 8618249
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic use in acetaminophen poisoning: how does the route of N-acetylcysteine administration affect utilization?
Miller MA; Navarro M; Bird SB; Donovan JL
J Med Toxicol; 2007 Dec; 3(4):152-6. PubMed ID: 18072168
[TBL] [Abstract][Full Text] [Related]
4. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication.
Tobias JD; Gregory DF; Deshpande JK
Pediatr Emerg Care; 1992 Dec; 8(6):345-6. PubMed ID: 1360651
[TBL] [Abstract][Full Text] [Related]
5. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management.
Dart RC; Erdman AR; Olson KR; Christianson G; Manoguerra AS; Chyka PA; Caravati EM; Wax PM; Keyes DC; Woolf AD; Scharman EJ; Booze LL; Troutman WG;
Clin Toxicol (Phila); 2006; 44(1):1-18. PubMed ID: 16496488
[TBL] [Abstract][Full Text] [Related]
6. Costs of treating and preventing nausea and vomiting in patients receiving chemotherapy.
Stewart DJ; Dahrouge S; Coyle D; Evans WK
J Clin Oncol; 1999 Jan; 17(1):344-51. PubMed ID: 10458253
[TBL] [Abstract][Full Text] [Related]
7. Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose.
Wright RO; Anderson AC; Lesko SL; Woolf AD; Linakis JG; Lewander WJ
J Toxicol Clin Toxicol; 1999; 37(1):35-42. PubMed ID: 10078158
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo.
Hill RP; Lubarsky DA; Phillips-Bute B; Fortney JT; Creed MR; Glass PS; Gan TJ
Anesthesiology; 2000 Apr; 92(4):958-67. PubMed ID: 10754614
[TBL] [Abstract][Full Text] [Related]
9. Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis.
Yarboro CH; Wesley R; Amantea MA; Klippel JH; Pucino F
Ann Pharmacother; 1996; 30(7-8):752-5. PubMed ID: 8826554
[TBL] [Abstract][Full Text] [Related]
10. Is ondansetron cost effective?
Bonneterre J
Pharmacoeconomics; 1994 Dec; 6(6):581-3. PubMed ID: 10155287
[TBL] [Abstract][Full Text] [Related]
11. Changing the Management of Paracetamol Poisoning.
Bateman DN
Clin Ther; 2015 Sep; 37(9):2135-41. PubMed ID: 26233473
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
Mayhall EA; Gray R; Lopes V; Matteson KA
Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
[TBL] [Abstract][Full Text] [Related]
13. Nurses' perceptions of antiemetic effectiveness.
Rhodes VA; McDaniel RW; Simms SG; Johnson M
Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery.
Watcha MF; Smith I
J Clin Anesth; 1994; 6(5):370-7. PubMed ID: 7986508
[TBL] [Abstract][Full Text] [Related]
15. A retrospective evaluation of shortened-duration oral N-acetylcysteine for the treatment of acetaminophen poisoning.
Betten DP; Burner EE; Thomas SC; Tomaszewski C; Clark RF
J Med Toxicol; 2009 Dec; 5(4):183-90. PubMed ID: 19876849
[TBL] [Abstract][Full Text] [Related]
16. Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity.
Martello JL; Pummer TL; Krenzelok EP
Clin Toxicol (Phila); 2010 Jan; 48(1):79-83. PubMed ID: 20095817
[TBL] [Abstract][Full Text] [Related]
17. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
18. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.
Bateman DN; Dear JW; Thanacoody HK; Thomas SH; Eddleston M; Sandilands EA; Coyle J; Cooper JG; Rodriguez A; Butcher I; Lewis SC; Vliegenthart AD; Veiraiah A; Webb DJ; Gray A
Lancet; 2014 Feb; 383(9918):697-704. PubMed ID: 24290406
[TBL] [Abstract][Full Text] [Related]
19. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
Gebbia V; Testa A; Cannata G; Gebbia N
Anticancer Drugs; 1996 Sep; 7(7):734-7. PubMed ID: 8949983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
